Muallem MZ - Search Results

1

Ten years of live surgical broadcast at Charité-MAYO conferences (2010-2019): a systematic evaluation of the surgical outcome.

Altmann J, Chekerov R, Fotopoulou C, Muallem MZ, du Bois A, Cliby W, Dowdy S, Podratz K, Lichtenegger W, Camara O, Tunn R, Cibula D, Kuemmel S, Scambia G, Vergote I, Chiantera V, Pietzner K, Inci MG, Chopra S, Biebl M, Neymeyer J, Blohmer JU, Sehouli J. Altmann J, et al. Among authors: muallem mz. Int J Gynecol Cancer. 2022 Jun 6;32(6):746-752. doi: 10.1136/ijgc-2021-003173. Int J Gynecol Cancer. 2022. PMID: 35383091

2

Vaginal fistula in a patient with relapsed ovarian cancer and amelanotic melanoma.

Muallem MZ, Yildiz S, Arsenic R, Trefzer U, Sehouli J. Muallem MZ, et al. Anticancer Res. 2012 May;32(5):1737-42. Anticancer Res. 2012. PMID: 22593454

3

HE4 tissue expression in borderline ovarian tumors: a pilot study by the tumorbank ovarian cancer network.

Nassir M, Darb-Esfahani S, Richter R, Chekerov R, Hall C, Muallem MZ, Denkert C, Stamatian F, Fotopoulou C, Sehouli J, Braicu EI. Nassir M, et al. Among authors: muallem mz. Anticancer Res. 2013 Apr;33(4):1673-7. Anticancer Res. 2013. PMID: 23564814

4

Survey among German gynecologists on the clinical management of patients with sarcomas of the uterus.

Chen FC, David M, Richter R, Muallem MZ, Chekerov R, Sehouli J. Chen FC, et al. Among authors: muallem mz. Anticancer Res. 2013 Aug;33(8):3375-81. Anticancer Res. 2013. PMID: 23898107

5

Laparoscopic radical hysterectomy and lymph node dissection learning experience at campus Virchow - Charite.

Muallem MZ, Feldheiser A, Sehouli J. Muallem MZ, et al. Anticancer Res. 2013 Aug;33(8):3449-53. Anticancer Res. 2013. PMID: 23898118

6

HE4 expression in plasma correlates with surgical outcome and overall survival in patients with first ovarian cancer relapse.

Braicu EI, Chekerov R, Richter R, Pop C, Nassir M, Loefgren H, Stamatian F, Muallem MZ, Hall C, Fotopoulou C, Sehouli J, Pietzner K. Braicu EI, et al. Among authors: muallem mz. Ann Surg Oncol. 2014 Mar;21(3):955-62. doi: 10.1245/s10434-013-3347-1. Epub 2013 Nov 12. Ann Surg Oncol. 2014. PMID: 24217786

7

ERCC1 expression as a predictor of resistance to platinum-based chemotherapy in primary ovarian cancer.

Muallem MZ, Braicu I, Nassir M, Richter R, Sehouli J, Arsenic R. Muallem MZ, et al. Anticancer Res. 2014 Jan;34(1):393-9. Anticancer Res. 2014. PMID: 24403493

8

ERCC1 expression as a predictive marker of cervical cancer treated with cisplatin-based chemoradiation.

Muallem MZ, Marnitz S, Richter R, Köhler C, Sehouli J, Arsenic R. Muallem MZ, et al. Anticancer Res. 2014 Jan;34(1):401-6. Anticancer Res. 2014. PMID: 24403494

9

AGO Score As a Predictor of Surgical Outcome at Secondary Cytoreduction in Patients with Ovarian Cancer.

Muallem MZ, Gasimli K, Richter R, Almuheimid J, Nasser S, Braicu EI, Sehouli J. Muallem MZ, et al. Anticancer Res. 2015 Jun;35(6):3423-9. Anticancer Res. 2015. PMID: 26026105 Clinical Trial.

10

Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.

Gasimli K, Braicu EI, Nassir M, Richter R, Babayeva A, Chekerov R, Darb-Esfahani S, Sehouli J, Muallem MZ. Gasimli K, et al. Among authors: muallem mz. Ann Surg Oncol. 2016 Apr;23(4):1279-86. doi: 10.1245/s10434-015-4959-4. Epub 2016 Jan 29. Ann Surg Oncol. 2016. PMID: 26832880

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page